Acceptance of hip protectors for hip fracture prevention in nursing homes

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
M Hubacher, A Wettstein

Abstract

In order to prevent hip fractures 548 fall-prone senior citizens living in 20 nursing homes participated in a randomized controlled trial of hip protectors. One hundred and sixty-four were randomly selected into the control group and 384 into the intervention group. Of the patients in the intervention group 138 (35.9%) wore the protector throughout the whole 10 months of the study's duration, 124 (32.3%) quit wearing the protectors after an initial wearing period and 122 (31.8%) refused to wear them at all. The regular wearers had the protector on during an average of roughly 12 hours a day, so they were protected for 50% of their exposure time (including at night). Fifty-nine percent of the drop-outs stopped wearing the protectors in the first two study months, mostly for non-medical reasons. Calculation by a forecasting model showed that those senior citizens who were initially prepared to wear the protector tended to be those who were physically restricted.

Citations

May 5, 2005·Irish Journal of Medical Science·C W FanC Cunningham
Jul 2, 2005·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Anna M SawkaJonathan D Adachi
Jan 13, 2009·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·T KoikeK Takaoka
Oct 7, 2009·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·I D CameronD P Kiel
Mar 2, 2011·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J-J BodyJ-Y Reginster
Oct 9, 2007·Wiener medizinische Wochenschrift·Lukas A Holzer, Gerold Holzer
Aug 30, 2008·HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery·Michael J GardnerJoseph M Lane
May 14, 2005·Journal of the American Medical Directors Association·Cathleen S Colón-EmericKenneth W Lyles
Dec 12, 2003·Joint, Bone, Spine : Revue Du Rhumatisme·Xavier Deprez, Patrice Fardellone
Jul 16, 2002·Current Opinion in Rheumatology·Julie T Lin, Joseph M Lane
Jun 24, 2003·Current Opinion in Rheumatology·Theodore T Suh, Kenneth W Lyles
Mar 4, 2006·BMJ : British Medical Journal·Martyn J ParkerLesley D Gillespie
Dec 8, 2004·Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention·L ForsénA J Søgaard
Jun 18, 2003·Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention·I D CameronT Finnegan
Aug 14, 2008·Clinical Trials : Journal of the Society for Clinical Trials·Bruce A BartonDouglas P Kiel
Jan 5, 2011·Journal of the American Medical Directors Association·Ian D CameronFrederieke F Schaafsma
Jun 4, 2008·Journal of the American Medical Directors Association·Doron GarfinkelJoshua Ben-Israel
Apr 22, 2008·Medical Engineering & Physics·Marianne Schmid DanersKai-Uwe Schmitt
Jan 28, 2005·Journal of the American Geriatrics Society·Lisa A HonkanenMark S Lachs
Nov 8, 2006·Journal of the American Geriatrics Society·Lisa A HonkanenBruce R Schackman
Feb 21, 2006·International Journal of Nursing Studies·Peter D O'HalloranLiam J Murray
Jul 2, 2005·Medical Engineering & Physics·Siegfried DerlerK-U Schmitt
May 1, 2015·Calcified Tissue International·Luisella CianferottiMaria Luisa Brandi
Feb 24, 2015·Journal of the American Medical Directors Association·Alexandra M B KorallLisa Lin
May 6, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Lisa WaldeggerDoug Coyle
Mar 22, 2014·Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society·Joanie Sims-GouldStephen N Robinovitch
Apr 2, 2014·The Cochrane Database of Systematic Reviews·Nancy SantessoRomina Brignardello-Petersen
May 4, 2002·Stroke; a Journal of Cerebral Circulation·Kenneth E S PooleElizabeth A Warburton
Mar 10, 2016·The Journal of Trauma and Acute Care Surgery·Marie CrandallRobert Barraco
Dec 27, 2016·BoneKEy Reports·Peter VargaMarkus Windolf
Aug 22, 2008·European Journal of Ageing·Hege BentzenLisa Forsén

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
A HaradaN Niino
JAMA : the Journal of the American Medical Association
N M van SchoorP Lips
© 2021 Meta ULC. All rights reserved